ClassID:

95841

C07F9/10 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds without P—C bonds; Esters of oxyacids of phosphorus; Esters of phosphoric acids Phosphatides, e.g. lecithin

Sub-classes:
Recent Application in this class:
#1
20260097111
2026-04-09

ETHER LIPIDS FOR HYPERACTIVATION OF MAMMALIAN DENDRITIC CELLS

#2
20260069540
2026-03-12

GENE DELIVERY AGENTS

#3
20250345290
2025-11-13

APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF

#4
20250326873
2025-10-23

DUAL-PHASE ZWITTERIONIC MONOMERS

#5
20250276046
2025-09-04

SELF-ASSEMBLING OXYGEN CARRIER COMPOSITIONS

#6
20250262171
2025-08-21

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

#7
20250215026
2025-07-03

Deuterated Compounds, Compositions and Uses

#8
20250144233
2025-05-08

NOVEL GENE DELIVERY AGENTS

#9
20250092174
2025-03-20

DUAL-PHASE ZWITTERIONIC MONOMERS

#10
20250011347
2025-01-09

NOVEL PLASMALOGEN DERIVATIVE

#11
20240409565
2024-12-12

POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS

#12
20240409487
2024-12-12

COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF INFLAMMATORY, DEGENERATIVE, AND NEURODEGENERATIVE DISEASES

#13
20240245618
2024-07-25

COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS

#14
20240099993
2024-03-28

ARTIFICIALLY SYNTHESIZED SPHINGOSINE DERIVATIVE LIPOID MONOMER AND USE OF SAME FOR DELIVERING NUCLEIC ACID

#15
20240026049
2024-01-25

DUAL-PHASE ZWITTERIONIC MONOMERS

#16
20230310610
2023-10-05

Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents

#17
20230303598
2023-09-28

BIOINSPIRED LIPID DERIVATIVES AND USES THEREOF

#18
20230064920
2023-03-02

PROCESS OF PREPARING ARACHIDONOYLETHANOLAMINE ANALOGUES

#19
20230047556
2023-02-16

ANTI-INFLAMMATORY PROPERTIES OF MARINE LIPID COMPOSITIONS

#20
20220348544
2022-11-03

Ketamine compounds and processes for making and using them

#21
20220162238
2022-05-26

FATTY ACID COMPOSITION AND APPLICATION THEREOF

#22
20220142949
2022-05-12

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

#23
20220119428
2022-04-21

PHOSPHOLIPIDATION OF IMIDAZOQUINOLINES AND OXOADENINES

#24
20220071916
2022-03-10

Compositions and methods for organ specific delivery of nucleic acids

#25
20220009950
2022-01-13

DEUTERATED COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

#26
20210330754
2021-10-28

Self-assembling oxygen carrier compositions

#27
20210323984
2021-10-21

Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells

#28
20210198501
2021-07-01

Infrared absorbing nanoparticle(s)

#29
20210108198
2021-04-15

APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF

#30
20210024553
2021-01-28

Phospholipidation of imidazoquinolines and oxoadenines

#31
20210015767
2021-01-21

Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid

#32
20210008203
2021-01-14

Long-lived gadolinium based tumor targeted imaging and therapy agents

#33
20200330407
2020-10-22

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

#34
20200255366
2020-08-13

Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases

#35
20200215085
2020-07-09

Method to Abate Acute Airway Hypersensitivity and Asthma Attacks

#36
20200179416
2020-06-11

Anti-inflammatory properties of marine lipid compositions

#37
20200157127
2020-05-21

Phospholipid analogues

#38
20200123188
2020-04-23

Synthetic molecule constructs

#39
20200102333
2020-04-02

Phospholipid derivatives and their use as medicaments

#40
20200031853
2020-01-30

Lipid derivative for nucleic acid introduction

#41
20190352316
2019-11-21

Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells

#42
20190184014
2019-06-20

Long-lived gadolinium based tumor targeting imaging and therapy agents

#43
20190091180
2019-03-28

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

#44
20190070203
2019-03-07

Anti-inflammatory properties of marine lipid compositions

#45
20190060332
2019-02-28

Concentrated therapeutic phospholipid compositions

#46
20180327433
2018-11-15

Ether phospholipids and method for producing the same

#47
20180325924
2018-11-15

Methods and compositions for enriching DHA levels in the brain

#48
20180298041
2018-10-18

Phosphate composition

#49
20180297938
2018-10-18

Compounds for targeting drug delivery and enhancing siRNA activity

#50
20180289638
2018-10-11

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

#51
20180284143
2018-10-04

Method for quantifying plasmalogens using PLA1 processing

#52
20180273560
2018-09-27

Phospholipidation of imidazoquinolines and oxoadenines

#53
20180273554
2018-09-27

Lipophenol compounds and uses thereof

#54
20180251752
2018-09-06

Phospholipid nanogel for exoglycosidase enzyme stabilization

#55
20180127680
2018-05-10

METHOD FOR PRODUCING ETHER PHOSPHOLIPIDS

#56
20180094008
2018-04-05

Method for purification of lecithin

#57
20180057518
2018-03-01

Synthetic membrane anchors

#58
20180044278
2018-02-15

Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases

#59
20170355721
2017-12-14

Siloxane-containing phospholipids, compositions and uses thereof

#60
20170342097
2017-11-30

Methods and compositions to treat type-1 and type-2 diabetes

#61
20170261481
2017-09-14

Protein adsorption inhibitor and method for inhibiting protein adsorption

#62
20170240597
2017-08-24

In vivo methods of monitoring biodistribution

#63
20170226499
2017-08-10

Protein-stabilizing agent and protein-stabilizing method

#64
20170128572
2017-05-11

Long-lived gadolinium based tumor targeted imaging and therapy agents

#65
20170120163
2017-05-04

Separation material comprising phosphoryl choline derivatives

#66
20170037067
2017-02-09

Lipophenol compounds and uses thereof

#67
20170029448
2017-02-02

Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells

#68
20170008917
2017-01-12

Method for preparing racemic or optically active α-glycerophosphorylcholine

#69
20170001950
2017-01-05

Compounds for targeting drug delivery and enhancing siRNA activity

#70
20170000893
2017-01-05

Compounds for targeting drug delivery and enhancing siRNA activity

#71
20160375043
2016-12-29

Concentrated therapeutic phospholipid compositions

#72
20160333044
2016-11-17

Synthetic membrane anchors

#73
20160272660
2016-09-22

Method for the purification of lecithin

#74
20160136092
2016-05-19

Stereospecific lipids for locoregional therapy with long-term circulating stimuli-sensitive nanocarrier systems

#75
20160096854
2016-04-07

METHOD FOR SUPPRESSING HEAT DISCOLORATION OF LECITHIN

#76
20160075634
2016-03-17

Methods for the synthesis of sphingomyelins and dihydrosphingomyelins

#77
20160015820
2016-01-21

Glycerophospholipids for the improvement of cognitive functions

#78
20150315217
2015-11-05

Method of Making Small Liposomes

#79
20150315216
2015-11-05

PHOSPHATE COMPOSITION

#80
20150291637
2015-10-15

Method for the fractionation of phospho-lipids from phospholipid-containing material

#81
20140364399
2014-12-11

Phospholipid compositions enriched for palmitoleic, myristoleic or lauroleic acid, their preparation and their use in treating metabolic and cardiovascular disease

#82
20140323749
2014-10-30

Methods for the synthesis of 13C labeled plasmalogen

#83
20140296548
2014-10-02

Membrane Precursors and Membranes Formed Therefrom

#84
20140186950
2014-07-03

Synthetic membrane anchors

#85
20140161723
2014-06-12

In vivo methods of monitoring biodistribution

#86
20140148415
2014-05-29

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

#87
20140141074
2014-05-22

Concentrated therapeutic phospholipid compositions

#88
20140051663
2014-02-20

Glycerophospholipids for the improvement of cognitive functions

#89
20130225526
2013-08-29

Medicine, food and drink or feed containing sphingomyelin

#90
20130202689
2013-08-08

NATURAL MARINE SOURCE PHOSPHOLIPIDS COMPRISING POLYUNSATURATED FATTY ACIDS AND THEIR APPLICATIONS

#91
20130158283
2013-06-20

Process for the preparation of oxidized phospholipids

#92
20130017249
2013-01-17

Compounds for targeting drug delivery and enhancing siRNA activity

#93
20130017248
2013-01-17

Cationic Liposomes And Method of Use

#94
20120329757
2012-12-27

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#95
20120277196
2012-11-01

Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

#96
20120270780
2012-10-25

Method and composition for modulating erythropoiesis

#97
20120264966
2012-10-18

SULFUR-CONTAINING PHOSPHOLIPID DERIVATIVES

#98
20120258165
2012-10-11

Phospholipid derivative and pH-responsive liposomes

#99
20120232298
2012-09-13

Compounds for preparing immunological adjuvant

#100
20120215006
2012-08-23

Synthesis of phosphoric esters

#101
20120214771
2012-08-23

COMPOSITIONS FOR TREATMENT OF CARDIOMETABOLIC DISORDERS

#102
20120208783
2012-08-16

Medicine, Food And Drink Or Feed Containing Sphingomyelin

#103
20120172631
2012-07-05

PHOSPHATIDYL OLIGOGLYCEROLS

#104
20120130108
2012-05-24

PROCESS FOR THE PREPARATION OF OXIDIZED PHOSPHOLIPIDS

#105
20120065416
2012-03-15

Methods for Production of Biodiesel

#106
20120065172
2012-03-15

Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

#107
20120034294
2012-02-09

METHOD OF MAKING SMALL LIPOSOMES

#108
20120028922
2012-02-02

Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

#109
20120009246
2012-01-12

Phospholipid-analogous compounds

#110
20110257133
2011-10-20

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

#111
20110217783
2011-09-08

Cleavable surfactants and methods of use thereof

#112
20110213134
2011-09-01

Synthetic membrane anchors

#113
20110195937
2011-08-11

Oxidized thiophospholipid compounds and uses thereof

#114
20110189212
2011-08-04

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#115
20110183421
2011-07-28

COMPOSITION AND METHOD FOR CONVERTING A NON-PATHOGENIC PRION PROTEIN INTO A PATHOGENIC CONFORMATION AND USES THEREOF

#116
20110160161
2011-06-30

Concentrated therapeutic phospholipid compositions

#117
20110152218
2011-06-23

CRYSTALLINE PHOSPHOLIPID, METHOD FOR ITS PRODUCTION AND USE IN TREATING DAMAGED TISSUE

#118
20110144063
2011-06-16

Glycerophospholipids for the improvement of cognitive functions

#119
20110118489
2011-05-19

Membrane precursors and membranes formed therefrom

#120
20110111469
2011-05-12

Process for the production of N-acyl-phosphatidyl-ethanolamine

#121
20110104359
2011-05-05

Lecithin Based Composition And Its Use In Food

#122
20110097350
2011-04-28

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#123
20110077224
2011-03-31

Linoleic phospholipids and uses thereof for inhibiting inflammatory and neurodegenerative processes

#124
20110040108
2011-02-17

Inositolphospholipids and analogues phosphatidylinositol products and processes

#125
20100317881
2010-12-16

Process for the preparation of oxidized phospholipids

#126
20100316680
2010-12-16

Anti-inflammatory properties of marine lipid compositions

#127
20100280282
2010-11-04

Phosphatidyl oligoglycerols

#128
20100197951
2010-08-05

Compounds for preparing immunological adjuvant

#129
20100184718
2010-07-22

Compositions and methods for double-targeting virus infections and targeting cancer cells

#130
20100183705
2010-07-22

Phospholipid-analogous compounds

#131
20100172967
2010-07-08

COMPOUND MODIFIED WITH GLYCEROL DERIVATIVE

#132
20100160259
2010-06-24

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

#133
20100086583
2010-04-08

Lipid-analogous phosphoric triesters

#134
20100048928
2010-02-25

Medicine, Food and Drink or Feed Containing Sphingomyelin

#135
20100048515
2010-02-25

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#136
20100022001
2010-01-28

Cationic Liposomes And Method of Use

#137
20100003761
2010-01-07

Methods for the diagnosis of dementia and other neurological disorders

#138
20090232880
2009-09-17

Analogue compounds of archaebacterial membrane lipids and liposomal compounds integrating such compounds

#139
20090221684
2009-09-03

Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof

#140
20090209775
2009-08-20

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#141
20090074857
2009-03-19

Glycerophospholipids for the improvement of cognitive functions

#142
20090042021
2009-02-12

Metal-coated lipid bilayer vesicles and process for producing same

#143
20090035358
2009-02-05

Phosphatidyl oligoglycerols

#144
20080312459
2008-12-18

Method for the synthesis of phospholipid ethers

#145
20080293667
2008-11-27

Lipid analogs for combating tumors

#146
20080286351
2008-11-20

Pegylated Cardiolipin Analogs, Methods of Synthesis, and Uses Thereof

#147
20080275006
2008-11-06

Process for the preparation and isolation of phosphatides

#148
20080261865
2008-10-23

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#149
20080214849
2008-09-04

Phospholipids with unsaturated alkyl and acyl chains

#150
20080200425
2008-08-21

Methods and compositions for regulating bone mineral density

#151
20080199454
2008-08-21

Caspase inhibitor prodrugs

#152
20080090781
2008-04-17

Formulations containing alkylphosphocholines using novel negative charge carriers

#153
20080064889
2008-03-13

Process for Recovering Oils Entrained by Gums Separated During a Degumming Process for Oils made from Oilseeds and Parts thereof, Lecithins Obtained by said Process, and Solvent-Extracted Meals Comprising a Substantially Higher Protein Content

#154
20080044487
2008-02-21

Anti-inflammatory properties of marine lipid compositions

#155
20080014253
2008-01-17

Lipid-Based Drug Delivery Systems Containing Unnatural Phospholipase A2 Degradable Lipid Derivatives and the Therapeutic Uses Thereof

#156
20070197466
2007-08-23

Synthetic membrane anchors

#157
20070191310
2007-08-16

Phospholipid derivatives of non-steroidal anti-inflammatory drugs

#158
20070189974
2007-08-16

Glycerophosphoric acid ester derivative having polyfunctional metal chelate structure

#159
20070161604
2007-07-12

Highly active lysophosphatidic acid and method of screening therewith

#160
20070142653
2007-06-21

Inositolphospholipids and analogues: phosphatidylinositol products and processes

#161
20070135381
2007-06-14

Derivatives of branch-chain lipophilic molecular and uses thereof

#162
20070112211
2007-05-17

Process for the preparation of oxidized phospholipids

#163
20070105823
2007-05-10

Glycero-compound having triple bond and membrane material containing the same

#164
20070105812
2007-05-10

Lipid analogs for inhibiting HIV-1 activity

#165
20070105811
2007-05-10

Lipid analogs for inhibiting the activity of hepatitis B antigen

#166
20070099870
2007-05-03

Lipid analogs for combating tumors

#167
20070099868
2007-05-03

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#168
20070082875
2007-04-12

Compounds for preparing immunological adjuvant

#169
20070031481
2007-02-08

Phospholipid derivative

#170
20070026384
2007-02-01

Detection of transmembrane potentials by optical methods

#171
20060281715
2006-12-14

Phosphates of secondary alcohols

#172
20060280784
2006-12-14

Compound modified with glycerol derivative

#173
20060264397
2006-11-23

Compositions and methods for targeting cancer cells

#174
20060240562
2006-10-26

CLEAVABLE SURFACTANTS AND METHODS OF USE THEREOF

#175
20060239926
2006-10-26

Specific high-relaxivity compounds

#176
20060210618
2006-09-21

Phospholipid derivatives and process for the production there

#177
20060159738
2006-07-20

Cationic liposomes and methods of use

#178
20060135765
2006-06-22

Antineoplastic ether lipid compounds

#179
20060122153
2006-06-08

Antineoplastic ether lipid compounds with modifications at the sn-2 carbon

#180
20060116354
2006-06-01

Antineoplastic ether lipid compounds with modifications at the sn-3 carbon

#181
20060105996
2006-05-18

Inositolized phospholipids

#182
20060105987
2006-05-18

Sulfur-containing phospholipid derivatives

#183
20060088582
2006-04-27

Phosphatidyl oligo glycerins and structural analogs

#184
20060079703
2006-04-13

Process for preparing lysophosphatidylcholine

#185
20060079486
2006-04-13

Lipopolymer conjugates

#186
20060062726
2006-03-23

Glycerol ester derivative

#187
20060039963
2006-02-23

Lipid-analogous phosphoric acid triesters

#188
20060008518
2006-01-12

Sphingomyelin analogues and a process for preparation thereof

#189
20050287076
2005-12-29

Compounds for use as surfactants

#190
20050272813
2005-12-08

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#191
20050266068
2005-12-01

Cardiolipin molecules and methods of synthesis

#192
20050250189
2005-11-10

Process for recovering serine

#193
20050221987
2005-10-06

Use of certain phospholipids to deliver hormonal effects to plants

#194
20050220856
2005-10-06

Phospholipid derivative

#195
20050181037
2005-08-18

Cardiolipin compositions their methods of preparation and use

#196
20050165245
2005-07-28

Phospholipid-analogous compounds

#197
20050164988
2005-07-28

Immunomodulatory compounds and methods of use thereof

#198
20050123566
2005-06-09

Immunomodulatory compounds and methods of use thereof

#199
20050080050
2005-04-14

Lipid analogs for treating viral infections

#200
20050064532
2005-03-24

Compounds for determining the activity of phospholipase A

#201
20050033051
2005-02-10

Nucleosides preparation thereof and use as inhibitors of rna viral polymerases

#202
20050014722
2005-01-20

Process for preparing n-acylated lysophosphatidylcholine and pharmaceutical composition for treatment of metabolic bone disease comprising said compounds